story bloomberg starts follows james vestal texas urologist exposed patients unnecessary risk '' submitted false information required reports '' clinical trial prostate cancer drug according food drug administration agency drug division believes repeatedly deliberately violated regulations governing proper conduct clinical studies `` fda said letter vestal accordingly fda proposes disqualified clinical investigator `` fda send letter starting disciplinary action vestal may three years violations agency rules detailed reports fda staff investigators vestal continued conduct drug trials recently last year permitted stopped voluntarily negotiating fda case agency failed complete disciplinary action researchers including vestal proposing disqualified trials based findings violated rules designed protect patients ensure accurate data fda records show cases remained unresolved long decade read whole piece regular readers angered surprised david linden sex patients along transgressions gets slap limp noodle think linden record frightening check dr louis fabre whether serious scientific misconduct high level sexual misconduct whatever else penalty slap wrist expect p post effexor developing quite slowly i hope next week